KEDRION BIOPHARMA
Live / Allowed — Publication / registration review complete (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79428966
- Mark type
- Design + words
- Filed
- 10 Feb 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Lindsay M.R. Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of primary and secondary immunodeficiency disorders, coagulation disorders, autoimmune diseases treatable with immunoglobulins, and other conditions treatable with plasma derived therapies, biologic therapies, and small molecules therapies; Pharmaceutical preparations for the treatment of primary and secondary immunodeficiency disorders, coagulation disorders, autoimmune diseases treatable with immunoglobulins, and other conditions treatable with plasma derived therapies, biologic therapies, and small molecules therapies
- Class 035 — Advertising and business services: Business management; business administration; office functions in the nature of regulatory documentation management for biopharmaceutical activities and pharmaceutical regulatory compliance for others; Business administration in the nature of sales administration
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research, analysis, and testing, in the field of pharmaceuticals, medical disorders and the treatment of medical disorders, and clinical trials, ; medical and pharmacological research services; providing information and data in relation to medical research and development in the field of pharmaceuticals and clinical trials; providing scientific research information in the field of medical disorders and their treatment; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research; biological research, clinical research and medical research in the field of pharmaceuticals and clinical trials; design and development of computer software for use with medical technology; scientific research on the subject of pharmaceuticals; providing information technology services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products
- Class 044 — Medical, beauty and agricultural services: Medical services and small molecule therapy services; medical consultancy in relation to medical and pharmaceutical field; health center services for therapeutical purposes
Owner
- KEDRION S.p.A., IT
Prosecution history
- 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Oct 2025 — REFUSAL PROCESSED BY IB
- 24 Sept 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 24 Sept 2025 — REFUSAL PROCESSED BY MPU
- 12 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 11 Aug 2025 — NON-FINAL ACTION WRITTEN
- 02 Aug 2025 — ASSIGNED TO EXAMINER
- 01 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Jul 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB